Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention

Keyphrases

• Clinical Experience 100%
• Percutaneous Coronary Intervention 100%
• Triple Antithrombotic Therapy 100%
• Dual Antithrombotic Therapy 83%
• Cerebrovascular Accident 66%
• Adverse Cardiac Events 66%
• Aspirin 50%
• Confidence Interval 33%
• Drug-eluting Stent 33%
• Bioresorbable Vascular Scaffold 33%
• Bleeding 16%
• Clinical Practice 16%
• Hazard Ratio 16%
• Multivariable 16%
• Treatment Group 16%
• Clinical Benefit 16%
• Cox Proportional Hazards Model 16%
• Baseline Characteristics 16%
• Oral Anticoagulation 16%
• Cardiovascular Mortality 16%
• Major Bleeding 16%
• Bleeding Academic Research Consortium 16%
• Thrombolysis in Myocardial Infarction 16%
• Everolimus-eluting 16%
• Oral Anticoagulant Therapy 16%
• Clinical Outcomes 16%
• Scaffold Implantation 16%

Medicine and Dentistry

• Percutaneous Coronary Intervention 100%
• Antithrombotic Therapy 100%
• Acetylsalicylic Acid 27%
• Drug-Eluting Stent 18%
• Oral 18%
• Cardiovascular System 9%
• Bleeding 9%
• Myocardial Infarction 9%
• Hazard Ratio 9%
• Proportional Hazards Model 9%
• Blood Clot Lysis 9%
• Anticoagulation 9%
• Anticoagulant Therapy 9%
• Major Bleeding 9%
• Everolimus 9%
• Treatment Group 9%
• Primary Outcome 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Antithrombotic Therapy 100%
• Acetylsalicylic Acid 27%
• Bleeding 18%
• Anticoagulation Therapy 9%
• Heart Infarction 9%
• Everolimus 9%
• Treatment Group 9%